Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00961051 · ClinicalTrials.gov registry record · Phase 3
Evaluation of an Investigational Multi-Purpose Solution (MPS)
A Phase 3 study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- Phase 3
- Development phase
- 270
- Enrollment target
NCT00961051 is a Phase 3 study that has completed, run by Abbott Medical Optics. The registered enrollment target is 270 participants.
The verdict
NCT00961051, a Phase 3 study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of an investigational multi-purpose contact lens solution.
Interventions
- DEVICE Investigational MPS
- DEVICE Opti-Free
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00961051
The ClinicalTrials.gov registry entry for NCT00961051 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational MPS is the first listed.
NCT00961051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00961051 about?
NCT00961051 is a clinical study titled "Evaluation of an Investigational Multi-Purpose Solution (MPS)". The purpose of this study is to evaluate the safety and effectiveness of an investigational multi-purpose contact lens solution.
What is the current status of trial NCT00961051?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 270 participants. The study started on 2009-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00961051?
The interventions under investigation include: Investigational MPS (DEVICE), Opti-Free (DEVICE).
Who is sponsoring clinical trial NCT00961051?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.